| Dr James Atkinson Deer Iii, MD | |
|
2222 E. Highland Ave, Suite 221, Phoenix, AZ 85016-4872 | |
| (480) 665-9569 | |
| (602) 935-3069 |
| Full Name | Dr James Atkinson Deer Iii |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 15 Years |
| Location | 2222 E. Highland Ave, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952538027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 47663 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arkangel Endocrinology And Diabetes | 1355770256 | 2 |
News Archive
Today, Upp Technology, a leading provider of public health solutions, announced the new enhanced version of their irms|PM (Patient Management) software product.
Arizona State University (ASU) and China's Sun Yat-Sen University (SYSU) have formalized a research collaboration aimed at developing early and predictive diagnostics to improve patient outcomes for colorectal cancer.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that the Company has completed its acquisition of Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets.
Ospemifene (tradename: Senshio) is approved for the treatment of moderate to severe symptomatic vulvovaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy.
› Verified 9 days ago
| Entity Name | Arkangel Endocrinology & Diabetes |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770146466 PECOS PAC ID: 1355770256 Enrollment ID: O20200327001745 |
News Archive
Today, Upp Technology, a leading provider of public health solutions, announced the new enhanced version of their irms|PM (Patient Management) software product.
Arizona State University (ASU) and China's Sun Yat-Sen University (SYSU) have formalized a research collaboration aimed at developing early and predictive diagnostics to improve patient outcomes for colorectal cancer.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that the Company has completed its acquisition of Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets.
Ospemifene (tradename: Senshio) is approved for the treatment of moderate to severe symptomatic vulvovaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Atkinson Deer Iii, MD 2222 E Highland Ave Ste 221, Phoenix, AZ 85016-4987 Ph: (602) 675-1213 | Dr James Atkinson Deer Iii, MD 2222 E. Highland Ave, Suite 221, Phoenix, AZ 85016-4872 Ph: (480) 665-9569 |
News Archive
Today, Upp Technology, a leading provider of public health solutions, announced the new enhanced version of their irms|PM (Patient Management) software product.
Arizona State University (ASU) and China's Sun Yat-Sen University (SYSU) have formalized a research collaboration aimed at developing early and predictive diagnostics to improve patient outcomes for colorectal cancer.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that the Company has completed its acquisition of Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets.
Ospemifene (tradename: Senshio) is approved for the treatment of moderate to severe symptomatic vulvovaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy.
› Verified 9 days ago
Moustafa I Hazin, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |